This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR
CompletedOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
October 1, 2021
Primary Completion Date
November 1, 2022
Study Completion Date
November 1, 2023
Conditions
Breast Cancer
Trial Locations (1)
Unknown
Menofia university, Shibīn al Kawm
All Listed Sponsors
lead
Menoufia University
OTHER
NCT06595758 - This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR | Biotech Hunter | Biotech Hunter